Synapse - Works

Results (22057)

Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC)

Meeting Abstract

Hellmann, M. D.; Rizvi, N.; Gettinger, S. N.; Goldman, J.; Chow, L. Q.; Juergens, R.; Borghaei, H.; Brahmer, J.; Shen, Y.; Harbison, C. T.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses

Meeting Abstract

Gettinger, S. N.; Hellmann, M. D.; Shepherd, F. A.; Antonia, S. J.; Brahmer, J.; Chow, L. Q.; Goldman, J.; Juergens, R.; Borghaei, H.; Ready, N. E.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC)

Meeting Abstract

Gettinger, S. N.; Horn, L.; Ramalingam, S. S.; Spigel, D. R.; Paz-Ares, L.; Paik, P.; Reck, M.; Reckamp, K.; Mazieres, J.; Stinchcombe, T.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test

Meeting Abstract

Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Yu, H.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

A phase 1b study to evaluate the safety and antitumor activity of MEDI4736 in combination with tremelimumab in patients with advanced NSCLC

Meeting Abstract

Goldberg, S. B.; Balmanoukian, A.; Chaft, J.; Rizvi, N.; Sanborn, R. E.; Rebelatto, M. C.; Narwal, R.; Robbins, P. B.; Gu, Y.; Karakunnel, J. J.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents distinct cancer subtypes

Meeting Abstract

Schmid, P.; Kowanetz, M.; Koeppen, H.; Zou, W.; Wistuba, I.; Kockx, M.; Kadel, E. E.; Chaft, J.; Rizvi, N. A.; Hirsch, F. R.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement

Meeting Abstract

Varga, A.; Camidge, D. R.; Sequist, L. V.; Wakelee, H.; Ou, S. H.; Goldman, J. W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G. R.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Impact of white adipose tissue inflammation on survival in patients with squamous cell carcinoma of the oral tongue

Meeting Abstract

Iyengar, N.; Ghossein, R.; Kochhar, A.; Morris, L.; Zhou, X.; Morris, P.; Awad, M.; Fury, M.; Pfister, D.; Patel, S.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Re-treating with carboplatin and paclitaxel as first line therapy for recurrent endometrial cancer in patients who have previously received this regimen in the adjuvant setting

Meeting Abstract

Cadoo, K.; Halpenny, D.; Phillips, M.; Aghajanian, C.
European Journal of Cancer (2015)

Fulltext@MSK | Save

Assessment of genomic alterations in bladder adenocarcinoma and urachal adenocarcinoma

Meeting Abstract

Jordan, E.; Won, H.; Toubaji, A.; Bagrodia, A.; Desai, N.; Bajorin, D.; Rosenberg, J.; Bochner, B.; Kim, W.; Berger, M.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save